1. Home
  2. MBIO vs ORIS Comparison

MBIO vs ORIS Comparison

Compare MBIO & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • ORIS
  • Stock Information
  • Founded
  • MBIO 2015
  • ORIS 2014
  • Country
  • MBIO United States
  • ORIS China
  • Employees
  • MBIO N/A
  • ORIS N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • ORIS Farming/Seeds/Milling
  • Sector
  • MBIO Health Care
  • ORIS Consumer Staples
  • Exchange
  • MBIO Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • MBIO 4.7M
  • ORIS 5.3M
  • IPO Year
  • MBIO N/A
  • ORIS 2024
  • Fundamental
  • Price
  • MBIO $1.28
  • ORIS $0.12
  • Analyst Decision
  • MBIO
  • ORIS
  • Analyst Count
  • MBIO 0
  • ORIS 0
  • Target Price
  • MBIO N/A
  • ORIS N/A
  • AVG Volume (30 Days)
  • MBIO 90.7K
  • ORIS 16.0M
  • Earning Date
  • MBIO 11-07-2025
  • ORIS 01-01-0001
  • Dividend Yield
  • MBIO N/A
  • ORIS N/A
  • EPS Growth
  • MBIO N/A
  • ORIS N/A
  • EPS
  • MBIO N/A
  • ORIS 0.00
  • Revenue
  • MBIO N/A
  • ORIS $12,317,000.00
  • Revenue This Year
  • MBIO N/A
  • ORIS N/A
  • Revenue Next Year
  • MBIO N/A
  • ORIS N/A
  • P/E Ratio
  • MBIO N/A
  • ORIS $555.16
  • Revenue Growth
  • MBIO N/A
  • ORIS N/A
  • 52 Week Low
  • MBIO $0.89
  • ORIS $0.08
  • 52 Week High
  • MBIO $21.95
  • ORIS $56.01
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 45.30
  • ORIS 43.97
  • Support Level
  • MBIO $1.13
  • ORIS $0.11
  • Resistance Level
  • MBIO $1.20
  • ORIS $0.13
  • Average True Range (ATR)
  • MBIO 0.08
  • ORIS 0.01
  • MACD
  • MBIO 0.01
  • ORIS 0.00
  • Stochastic Oscillator
  • MBIO 62.05
  • ORIS 37.88

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: